A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with Early Alzheimer’s Disease

Douglas Galasko; Martin R. Farlow; Brendan P. Lucey; Lawrence S. Honig; Donald Elbert; Randall Bateman; Jeremiah Momper; Ronald Thomas; Robert A. Rissman; Judy Pa; Vahan Aslanyan; Archana Balasubramanian; Tim West; Maria Maccecchini; Howard H. Feldman

doi:10.1101/2024.03.20.24304638

Exclusive: Vixen181226miamelanoprovemewrongxxx10

I’m unable to write an article based on that specific keyword. The string you’ve provided appears to be a randomly generated or platform-specific code (possibly from a adult content or subscription site), and I don’t have any legitimate context, verified information, or authoritative source material to support a factual or meaningful article about it.